Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review
Journal of Neuropathology & Experimental Neurology · 2025
DOI: 10.1093/jnen/nlae135 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2025. Verfasst von Andrea Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Meningeal Neoplasms, Meningioma, Rubinstein-Taybi Syndrome. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Rubinstein-Taybi syndrome (RTS) is a congenital disorder with characteristic clinical manifestations. In the vast majority of cases, it is caused by mutations of the gene encoding the transcriptional co-activator cAMP-response element binding protein (CBP)-binding protein (CREBBP). It has been thought to be a tumor predisposition syndrome as RTS patients have an increased risk of developing tumors including meningiomas. However, RTS-associated meningiomas are rarely reported. We report a unique RTS-associated meningioma in which an oncogenic CREBBP mutation is identified. We also comprehensively review the reported RTS-associated meningiomas, from epidemiology and pathogenesis to clinicopathological characteristics and treatment. All RTS patients with meningiomas are female and have the exclusive mutations of CREBBP. In population-based studies RTS-associated meningiomas seem to develop at younger ages. Their pathogenesis may be driven by the CREBBP/CBP alterations resulting in aberrant signal transduction in the CBP-mediated signaling pathways. Meningiomas in RTS patients have common clinicopathological characteristics including comorbidity with other tumors, radiologically intra-osseous growth, and uncommon histopathology such as ossifying and secretory features. Given the genetic nature and rarity of RTS-associated meningiomas, further investigation of their characteristics may define molecular targets for improved therapeutic options for RTS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Surgery/Neurosurgery, McMaster University, Hamilton, Ontario, Canada.
- Department of Paediatric Laboratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Cynthia Hawkins, Jian-Qiang Lu
Zitieren
APA
Chen, A., Hart, S. L., Lannon, M., Hawkins, C., Reddy, K. K. V., & Lu, J. Q. (2025). Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae135
Vancouver
Chen A, Hart SL, Lannon M, Hawkins C, Reddy KKV, Lu JQ. Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review. Journal of Neuropathology & Experimental Neurology. 2025. doi:10.1093/jnen/nlae135
BibTeX
@article{Chen2025,
author = {Chen, Andrea and Hart, Shannon Louise and Lannon, Melissa and Hawkins, Cynthia and Reddy, Kesava K V and Lu, Jian-Qiang},
title = {Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
doi = {10.1093/jnen/nlae135}
}
EUVIMED